Google Inc (NASDAQ:GOOGL) has found a role to play in the health sciences field. The company is working on a number of medical-oriented projects. It hopes that its efforts will bring relief to patients out there and those at risk of certain diseases. The company is working on a pill that screens the blood for cancers as well as other diseases. The pill works by sending what are known as magnetic nanoparticles into the bloodstream of the user. Away from cancer detection, the company is also preparing to commercialize another device that helps with the monitoring of blood sugar using tears instead of blood.
Google Inc (NASDAQ:GOOGL) is already known as the world’s largest Internet search provider. The company is also into robotics with a number of acquisitions having been done recently to support robotics agenda in the company. However, the company’s plunge into the medical space is uncharacteristic of a technology company.
Several questions have been asked about whether Google Inc (NASDAQ:GOOGL)’s health science projects are feasible. According to observers, the company has exciting concepts but it may take years before its health science products reach the market. Such health science projects not only require a lot of research, but regulatory issues pose the greatest headache. The matter becomes even more complicated for Google given that its cancer-detecting pill, for example, will be inserted into the body of healthy people. In such cases, the regulator is usually very strict.
Nonetheless, the company’s proactive efforts in cancer-detection are commendable, experts say. It happens that in the commercial world, companies are more concerned about developing therapeutics than diagnostics. That means that Google Inc (NASDAQ:GOOGL)’s cancer-screening system will be important in the fight against cancer. The pill will be inserted into the body and will relay important details through a wearable device.
Google Inc (NASDAQ:GOOGL) is also working on a tool that will help with the monitoring of the blood sugar levels without drawing blood from the body. The specially designed lens that uses tears from the eye to monitor blood sugar is expected to be of great help to diabetics. The lens was developed by Microsoft Corporation (NASDAQ:MSFT), but Google with be responsible for its commercialization.
With challenges and opportunities presented in Google Inc (NASDAQ:GOOGL)’s health science projects, it remains to be seen what comes out of such efforts. For the company, Google X lab project was built with a view for such challenges.
Appaloosa Management Lp run by David Tepper’s holds around 600,000 shares of Google Inc (NASDAQ:GOOGL).